Latest Advances

  • Condition: Multicystic Peritoneal Mesothelioma
  • Journal: BJS open
  • Treatment Used: Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
  • Number of Patients: 40
  • Published —
The study researched the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating multicystic peritoneal mesothelioma.
  • Condition: Bronchial Stump Closure in Right Pneumonectomy
  • Journal: Journal of medical case reports
  • Treatment Used: Bronchial Mucosal Ablation
  • Number of Patients: 1
  • Published —
This case report describes a 70-year-old Japanese man diagnosed with malignant pleural mesothelioma (lung tumor from asbestos) who underwent bronchial mucosal ablation for bronchial stump closure in right pneumonectomy.
  • Condition: Malignant Pleural Mesothelioma (MPM)
  • Journal: Lancet (London, England)
  • Treatment Used: Nivolumab Plus Ipilimumab
  • Number of Patients: 713
  • Published —
This study evaluated the effectiveness of nivolumab plus ipilimumab in patients with unresectable (unable to be surgically removed) malignant pleural mesothelioma (a cancer of the lining of the lungs).
  • Condition: Peritoneal Well-Differentiated Papillary Mesothelioma (WDPM) Associated with Infertility in Woman
  • Journal: The Journal of international medical research
  • Treatment Used: Laparoscopic Surgery
  • Number of Patients: 1
  • Published —
This case report describes a 37-year-old woman diagnosed with a peritoneal well-differentiated papillary mesothelioma associated with infertility treated with laparoscopic surgery.
  • Condition: Malignant Pleural Mesothelioma
  • Journal: The Lancet. Oncology
  • Treatment Used: Surgery after Radiotherapy
  • Number of Patients: 102
  • Published —
The study researched the outcomes of surgery after radiotherapy for malignant pleural mesothelioma.
  • Condition: Malignant Pleural Mesothelioma
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Pembrolizumab versus Single-Agent Chemotherapy
  • Number of Patients: 144
  • Published —
The study researched the outcomes of pembrolizumab versus single-agent chemotherapy for treating malignant pleural meosthelioma.
  • Condition: Untreated Malignant Pleural Mesothelioma
  • Journal: The Lancet. Oncology
  • Treatment Used: Durvalumab
  • Number of Patients: 55
  • Published —
The study researched the safety and effectiveness of Durvalumab for patients with untreated malignant pleural mesothelioma.
  • Condition: Malignant Mesothelioma
  • Journal: Journal of investigative medicine high impact case reports
  • Treatment Used: Cisplatin, Pemetrexed, and Bevacizumab
  • Number of Patients: 1
  • Published —
This study considered a patient with malignant mesothelioma (aggressive tumors of the tissue lining the lungs, stomach, heart, and other organs usually associated with asbestos exposure) with no known asbestos exposure who was treated via cisplatin, pemetrexed, and bevacizumab.
  • Condition: Malignant Pleural Mesothelioma
  • Journal: Multimedia manual of cardiothoracic surgery : MMCTS
  • Treatment Used: Video-Assisted Biopsy and Talc Pleurodesis
  • Number of Patients: 1
  • Published —
This case report describes a 67-year-old patient with malignant pleural mesothelioma (pleural cavity disease) who underwent video-assisted thoracoscopic biopsy and talc pleurodesis.
Showing 1-12 of 69